Article citationsMore>>

Moss, A.C. and Peppercorn, M.A. (2007) The Risks and the Benefits of Mesalazine as a Treatment for Ulcerative Colitis. Expert Opinion on Drug Safety, 6, 99-107.
http://dx.doi.org/10.1517/14740338.6.2.99

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top